Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imrecoxib versus celecoxib in axial spondyloarthritis
ChiCTR-TRC-14004718Phase 4Completed
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Start
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of imrecoxib in axial spondyloarthritis (axSpA) (2 arms), sponsored by The First Affiliated Hospital of Zhengzhou University. Primary endpoints: Number of subjects achieving ASAS20, Number of subjects achieving ASAS40 and 7 more. Started Jun 2014; status: completed.
02
Drugs
imrecoxib
03
Conditions
axial spondyloarthritis (axSpA)
Beyond the preview
Go deeper on ChiCTR-TRC-14004718.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-14004718.